Editas Medicine

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). 

CEO
Gilmore O’Neill
CEOGilmore O’Neill
Employees
264
Employees264
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
264
Employees264

EDIT Key Statistics

Market cap
690.31M
Market cap690.31M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.90M
Average volume1.90M
High today
$10.76
High today$10.76
Low today
$9.97
Low today$9.97
Open price
$10.24
Open price$10.24
Volume
628.43K
Volume628.43K
52 Week high
$33.86
52 Week high$33.86
52 Week low
$9.59
52 Week low$9.59

Analyst ratings

44%

of 18 ratings
Buy
38.9%
Hold
44.4%
Sell
16.7%

EDIT Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.